Literature DB >> 16050571

Current issues in the pathology of ovarian cancer.

Joseph T Rabban1, Debra A Bell.   

Abstract

The majority of primary ovarian tumors are histologically classified as surface epithelial-stromal neoplasms. The malignant potential of such neoplasms may be categorized, on the basis of the extent of epithelial proliferation and stromal invasion, as benign, borderline or malignant. Recent efforts to further classify the malignant potential of such neoplasms have produced a new system for the histologic grading of ovarian carcinoma as well as new potential histologic predictors of behavior, including micropapillary morphology and stromal microinvasion in serous tumors. Among mucinous ovarian neoplasms, new criteria have been proposed to distinguish primary ovarian from metastatic carcinomas; the distinction may be difficult but has great clinical significance. The origin of ovarian mucinous tumors associated with pseudomyxoma peritonei has been reassessed. Finally, recent pathologic findings from prophylactic salpingo-oophorectomy specimens in patients with hereditary risks for ovarian carcinoma have highlighted the additional risk for fallopian tube carcinoma and primary peritoneal carcinoma. Special processing of the pathologic specimens is required to detect early and minimal neoplasia in this setting. These current issues in the pathology of ovarian carcinoma and their clinical significance form the basis of this review.

Entities:  

Mesh:

Year:  2005        PMID: 16050571

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  8 in total

Review 1.  Emerging roles of Kruppel-like factor 6 and Kruppel-like factor 6 splice variant 1 in ovarian cancer progression and treatment.

Authors:  Analisa DiFeo; Goutham Narla; John A Martignetti
Journal:  Mt Sinai J Med       Date:  2009-12

Review 2.  Palliative surgery versus medical management for bowel obstruction in ovarian cancer.

Authors:  Ali Kucukmetin; Raj Naik; Khadra Galaal; Andrew Bryant; Heather O Dickinson
Journal:  Cochrane Database Syst Rev       Date:  2010-07-07

3.  Paraneoplastic Cutaneous Mucinosis as Initial Presentation of Recurrence in an Operated Case of Carcinoma Ovary: True Extent of Recurrent Metastatic Disease Unveiled on 18F Fluoro-D-Glucose Positron Emission Tomography-Computed Tomography.

Authors:  Sarthak Tripathy; Sudheer Arava; Sreedharan Thankarajan Arun Raj; Sneha Prakash; Neha Pathak; Jahnvi Marachapu; Shamim Ahmed Shamim
Journal:  Indian J Nucl Med       Date:  2021-03-04

4.  Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutations.

Authors:  Aasia Saleemuddin; Ann K Folkins; Leslie Garrett; Judy Garber; Michael G Muto; Christopher P Crum; Shelley Tworoger
Journal:  Gynecol Oncol       Date:  2008-08-21       Impact factor: 5.482

5.  Human ovarian tumour-derived chaperone-rich cell lysate (CRCL) elicits T cell responses in vitro.

Authors:  G Li; Y Zeng; X Chen; N Larmonier; M Sepassi; M W Graner; S Andreansky; M A Brewer; E Katsanis
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

6.  Morphological and molecular basis of ovarian serous carcinoma.

Authors:  Daniel G Rosen; Zhihong Zhang; Weiwei Shan; Jinsong Liu
Journal:  J Biomed Res       Date:  2010-07

7.  Survival of Advanced Stage High-Grade Serous Ovarian Cancer Patients in the Republic of Macedonia.

Authors:  Igor Aluloski; Mile Tanturovski; Rubens Jovanovic; Slavica Kostadinova-Kunovska; Gordana Petrusevska; Igor Stojkovski; Bojana Petreska
Journal:  Open Access Maced J Med Sci       Date:  2017-11-20

Review 8.  Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma.

Authors:  Mohammad Ezzati; Amer Abdullah; Ahmad Shariftabrizi; June Hou; Michael Kopf; Jennifer K Stedman; Robert Samuelson; Shohreh Shahabi
Journal:  Int Sch Res Notices       Date:  2014-10-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.